Your browser doesn't support javascript.
loading
LONGITUDINAL MICROPERIMETRY EVALUATION AFTER INTRAVITREAL OCRIPLASMIN INJECTION FOR VITREOMACULAR TRACTION.
Cacciamani, Andrea; Gelso, Aldo; Simonett, Joseph M; Ripandelli, Guido; Pileri, Marco; Stirpe, Mario; Scarinci, Fabio.
Afiliación
  • Cacciamani A; *G.B. Bietti Eye Foundation-IRCCS, Rome, Italy; †Department of Ophthalmology, Clinica Villa dei Fiori, Acerra, Naples, Italy; ‡Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; and §Department of Ophthalmology, San Giovanni-Addolorata Hospital, Rome, Italy.
Retina ; 37(10): 1832-1838, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28033236
PURPOSE: To determine whether improvements in microperimetry testing are associated with anatomic resolution after ocriplasmin treatment in patients with symptomatic vitreomacular adhesion (VMA)/vitreomacular traction and relatively preserved baseline best-corrected visual acuity (BCVA). METHODS: Patients with vitreomacular traction received a single 125-µg intravitreal ocriplasmin injection and were followed longitudinally for 6 months with optical coherence tomography, BCVA testing, and microperimetry. Visual function changes were compared between eyes with and without VMA resolution on optical coherence tomography. RESULTS: Eleven of 16 eyes (68.8%) achieved VMA resolution after treatment. Mean baseline BCVA was relatively good (79 ± 3 Early Treatment Diabetic Retinopathy Study letters; 20/52); no patients had a ≥2-line improvement in BCVA over the 6-month follow-up period. In the group with VMA resolution, mean retinal sensitivity significantly increased in the central 4° (15.2 ± 1.9 dB vs. 18.9 ± 0.7 dB, P < 0.001) when comparing baseline and final follow-up microperimetry testing. No change in mean retinal sensitivity was found in the group without VMA resolution. CONCLUSION: Microperimetry demonstrates a significant gain in retinal sensitivity, particularly in the central 4° area, in eyes with anatomic resolution after treatment of vitreomacular traction with intravitreal ocriplasmin injection, even when no significant gain in BCVA is seen.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Enfermedades de la Retina / Agudeza Visual / Campos Visuales / Fibrinolisina / Desprendimiento del Vítreo / Pruebas del Campo Visual Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Retina Año: 2017 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Enfermedades de la Retina / Agudeza Visual / Campos Visuales / Fibrinolisina / Desprendimiento del Vítreo / Pruebas del Campo Visual Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Retina Año: 2017 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos